Experience of Monitoring Subcutaneous Biological Treatment (Adalimumab) by Nurses in Chronic Inflammatory Diseases

Statistics

Letter to the Editor

Monitorización por enfermería de la administración de tratamientos biológicos subcutáneos (adalimumab) en enfermedades inflamatorias crónicas

Lucinda Sánchez-Eslavaa, Hèctor Corominasb,

Corresponding author

Hector.corominas@sanitatintegral.org
vancor@yahoo.com

Corresponding author.

, Manel Rierac, Ramon Fígulsb

a Enfermera Hospital de Dia polivalente, Hospital Dos de Maig de Barcelona, Barcelona, Spain

b Unitat de Reumatologia, Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain

c Unitat de Reumatologia, Hospital Dos de Maig, Barcelona, Spain

Read

7957

Times
was read the article

2896

Total PDF

5061

Total HTML

Share statistics

Article information

ISSN: 21735743
Original language: English

DOI:10.1016/j.reumae.2011.04.001

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	3	10	13
2025 5	86	138	224
2025 4	66	40	106
2025 3	76	31	107
2025 2	61	36	97
2025 1	75	48	123
2024 12	29	44	73
2024 11	56	49	105
2024 10	41	27	68
2024 9	40	26	66
2024 8	55	41	96
2024 7	43	31	74
2024 6	39	22	61
2024 5	42	30	72
2024 4	43	30	73
2024 3	37	30	67
2024 2	33	29	62
2024 1	34	29	63
2023 12	34	36	70
2023 11	38	39	77
2023 10	43	34	77
2023 9	57	40	97
2023 8	67	18	85
2023 7	40	32	72
2023 6	33	27	60
2023 5	36	17	53
2023 4	21	13	34
2023 3	26	30	56
2023 2	48	29	77
2023 1	26	22	48
2022 12	58	42	100
2022 11	60	36	96
2022 10	47	47	94
2022 9	39	34	73
2022 8	52	31	83
2022 7	63	41	104
2022 6	79	30	109
2022 5	62	55	117
2022 4	47	58	105
2022 3	61	47	108
2022 2	45	38	83
2022 1	47	44	91
2021 12	23	35	58
2021 11	32	47	79
2021 10	45	56	101
2021 9	36	44	80
2021 8	33	45	78
2021 7	28	31	59
2021 6	32	40	72
2021 5	60	52	112
2021 4	141	99	240
2021 3	69	47	116
2021 2	51	32	83
2021 1	33	22	55
2020 12	37	19	56
2020 11	28	20	48
2020 10	22	13	35
2020 9	39	25	64
2020 8	21	16	37
2020 7	33	20	53
2020 6	39	26	65
2020 5	45	13	58
2020 4	31	14	45
2020 3	17	4	21
2020 2	2	0	2
2020 1	16	0	16
2019 9	4	0	4
2019 6	2	0	2
2019 3	2	0	2
2019 1	3	0	3
2018 5	7	0	7
2018 4	79	8	87
2018 3	53	5	58
2018 2	47	3	50
2018 1	46	2	48
2017 12	43	3	46
2017 11	43	4	47
2017 10	29	6	35
2017 9	44	22	66
2017 8	45	5	50
2017 7	37	10	47
2017 6	47	13	60
2017 5	35	13	48
2017 4	25	4	29
2017 3	20	32	52
2017 2	15	10	25
2017 1	25	4	29
2016 12	50	20	70
2016 11	38	1	39
2016 10	54	12	66
2016 9	47	6	53
2016 8	38	8	46
2016 7	36	6	42
2016 6	0	12	12
2016 5	0	9	9
2016 4	2	0	2
2016 3	1	10	11
2015 12	2	0	2
2015 8	3	0	3
2015 7	21	7	28
2015 6	27	6	33
2015 5	35	17	52
2015 4	28	11	39
2015 3	17	7	24
2015 2	35	8	43
2015 1	28	7	35
2014 12	33	12	45
2014 11	37	13	50
2014 10	37	9	46
2014 9	23	7	30
2014 8	25	19	44
2014 7	36	12	48
2014 6	41	15	56
2014 5	47	12	59
2014 4	51	7	58
2014 3	48	20	68
2014 2	47	16	63
2014 1	39	13	52
2013 12	28	8	36
2013 11	26	13	39
2013 10	51	7	58
2013 9	47	12	59
2013 8	44	17	61
2013 7	36	9	45
2013 6	34	7	41
2013 5	34	15	49
2013 4	42	18	60
2013 3	39	19	58
2013 2	35	16	51
2013 1	32	12	44
2012 12	32	14	46
2012 11	17	11	28
2012 10	19	18	37
2012 9	17	3	20
2012 7	2	0	2
2012 6	3	0	3
2012 5	3	0	3
2012 4	3	0	3
2012 3	2	0	2
2012 2	6	0	6
2012 1	6	0	6
2011 12	10	0	10
2011 11	6	0	6
2011 10	9	0	9

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter